The reforms center on rebate passthrough, increased transparency, standardized reporting, and expanded federal oversight
Both medications target the gut-brain connection to influence appetite, digestion, and metabolism: Clinical trials show that patients using Semaglutide or Tirzepatide under medical supervision can lose a significant percentage of body weight often more than with diet and exercise alone
Studies have found that most people regain weight after stopping the medication, with many returning to their original weight sometime in the first 1.7 years
In addition to the physical changes, the altered digestive process means that food spends less time in the stomach and intestines
Hard-boil 12 eggs
What's measured, and how it's measured within these studies, can greatly vary the outcomes